• Anne-Marie Dingemans
    Categories: ,

    EORTC brings together experts from medical societies to compile a consensus definition for synchronous oligometastatic non small cell lung cancer

  • ECCO 2019 European Cancer Summit
    Categories:

    EORTC driving the policy agenda for clinical cancer research in Europe

  • E2-RADIate

    PRESS RELEASE: EORTC and ESTRO announce E2-RADIatE platform’s first site activation for Oligometastatic Disease

  • Categories:

    EORTC at ISCB 40, Annual Conference of the International Society for Clinical Biostatistics

  • ASCO19 - Gemma-Kenter - study 55994 study

    Defining the best treatment for locally advanced cervical cancer

  • ASCO19 - Patrick Schöffski - study 1317

    Assessment of a potential new treatment option for patients with metastatic gastrointestinal stromal tumor (GIST) that may overcome resistance to established compounds

  • ASCO19 -Sylvie Bonvalot - STRASS study

    Looking for answers in the search for the best treatment of retroperitoneal sarcoma

  • ASCO19 - 18071 study - Prof. Eggermont
    Categories: ,

    Sustained long term survival benefit with adjuvant ipilimumab in patients with high risk stage III melanoma